EcoDrugPlus

Integrin Subunit Beta 1

Ensembl ID : ENSCLAG00000005152
Gene Symbol: ITGB1
2 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSCLAG00000003516
Gene Symbol: ITGB3
3 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSCLAG00000012736
Gene Symbol: ITGB5
2 Cross references
212 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSCLAG00000003399
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSCLAG00000009316
Gene Symbol: ITGB7
2 Cross references
159 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSCLAG00000006980
Gene Symbol: ITGB8
2 Cross references
207 Possible Orthologues:

Intercellular Adhesion Molecule 1

Ensembl ID : ENSCLAG00000005350
Gene Symbol: ICAM1
2 Cross references
94 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSCLAG00000002656
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Interleukin 5

Ensembl ID : ENSCLAG00000016772
Gene Symbol: IL5
2 Cross references
91 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSCLAG00000013186
Gene Symbol: IDH1
2 Cross references
230 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSCLAG00000014007
Gene Symbol: IDH2
2 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSCLAG00000016848
Gene Symbol: KLKB1
2 Cross references
209 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).